LONGEVITY VENTURE PARTNERS MANAGEMENT, LP

Thesis

Longevity Venture Partners (LVP) is an early-stage venture capital firm founded in 2020, with a distinct focus on the Silvertech, Healthcare, and Wellness sectors. The firm's investment thesis centers on improving the quality and longevity of the older and aging population, aiming to add "life to years" rather than just extending years. LVP primarily invests in early-stage ventures, specifically pre-seed and seed rounds. While the firm invests globally, it has a significant focus on Israeli and U.S.-based startups. Their investment strategy involves backing entrepreneurs creating technologies and services that address the evolving needs of an aging global population, aiming to enhance independence and well-being. LVP also scouts opportunities in adjacent sectors that align with their mission to increase independence for older adults. The firm aims to invest in four to six Israeli companies per year, providing capital, industry expertise, and access to their network and pilot ecosystem. The typical check size for Longevity Venture Partners ranges from $500,000 to $12.7 million.

Related lists

• Pre-seed Healthcare investors
• Seed-stage Healthcare investors
• Series C+ Healthcare investors